Hatteras Venture Partners — 2022 Investments
4 investments dated 2022 · listed companies and verified rows first · show all
Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management.
AI & Machine LearningDigital HealthHealthtechMedical DevicesChicago, US
Amit K. Gupta(Executive Officer, Director)Omer Inan(Co-founder, Chief Scientific Officer)Andrew Carek(Co-founder, Chief Technical Officer)Amit Gupta(Co-founder, Advisor)inMozziyar Etemadi(Co-founder, Head of AI)Omer Inan, PhD(Co-founder, Chief Scientific Officer)in
Board seatLauren Pierce Flickinger· per SEC Form D
Co-investorsBayMed Venture PartnersBroadview VenturesCross-Border Impact VenturesLaerdal Million Lives FundOSF VenturesPortal Innovations
BiotechRtp, US
Matthew Cohen(Director)Anil Goyal(Executive Officer, Director)Lev Osherovich(Director)Jenny Ting(Director)Mark Vellaca(Director)
BoardBenjamin Scruggs(Director)
Board seatMark Velleca· per SEC Form D · $4M raise · filed Jan 2023
Entegrion develops a point-of-care viscoelastic coagulation monitoring system (VCM) for rapid hemostasis assessment in clinical settings including trauma, surgery, and obstetrics.
BiotechDefense TechHealthtechMedical DevicesDurham, US
Bert Valada(President and CEO)Richard Martin(Executive Officer)Susan Reyer(Executive Officer)Michael Galiger(Executive Officer)John Mowell(Director)Thomas Edwards(Director)
Roobrik provides science-based online surveys, financial-readiness assessments, and chat tools that help prospective senior living residents and their families evaluate their options while converting more website visitors into qualified leads for senior living providers.
Digital HealthHealthtechMarketing TechSaaSSales TechGreensboro, US
Nathaniel O'Keefe(Executive Officer, Director)Nate O'Keefe(Founder)inJudith Conaway(Executive Officer)David Levin(Director)Maureen O'Connor(Director)William Clark(Director)
Co-investorsIDEA NCJurassic CapitalThe Launch PlaceThird Act Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.